BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33772794)

  • 1. LSD and ketanserin and their impact on the human autonomic nervous system.
    Olbrich S; Preller KH; Vollenweider FX
    Psychophysiology; 2021 Jun; 58(6):e13822. PubMed ID: 33772794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants.
    Becker AM; Klaiber A; Holze F; Istampoulouoglou I; Duthaler U; Varghese N; Eckert A; Liechti ME
    Int J Neuropsychopharmacol; 2023 Feb; 26(2):97-106. PubMed ID: 36342343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.
    Holze F; Vizeli P; Ley L; Müller F; Dolder P; Stocker M; Duthaler U; Varghese N; Eckert A; Borgwardt S; Liechti ME
    Neuropsychopharmacology; 2021 Feb; 46(3):537-544. PubMed ID: 33059356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the 5-HT
    Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
    J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
    Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
    Elife; 2018 Oct; 7():. PubMed ID: 30355445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.
    Kraehenmann R; Pokorny D; Vollenweider L; Preller KH; Pokorny T; Seifritz E; Vollenweider FX
    Psychopharmacology (Berl); 2017 Jul; 234(13):2031-2046. PubMed ID: 28386699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
    Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
    J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
    Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
    Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.
    Straumann I; Ley L; Holze F; Becker AM; Klaiber A; Wey K; Duthaler U; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2023 Dec; 48(13):1840-1848. PubMed ID: 37258715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.
    Strajhar P; Schmid Y; Liakoni E; Dolder PC; Rentsch KM; Kratschmar DV; Odermatt A; Liechti ME
    J Neuroendocrinol; 2016 Mar; 28(3):12374. PubMed ID: 26849997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making.
    Pokorny T; Duerler P; Seifritz E; Vollenweider FX; Preller KH
    Psychol Med; 2020 Oct; 50(13):2255-2264. PubMed ID: 31500679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.
    Bershad AK; Schepers ST; Bremmer MP; Lee R; de Wit H
    Biol Psychiatry; 2019 Nov; 86(10):792-800. PubMed ID: 31331617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA; Harvey JA; Aloyo VJ
    Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.
    Holze F; Ley L; Müller F; Becker AM; Straumann I; Vizeli P; Kuehne SS; Roder MA; Duthaler U; Kolaczynska KE; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2022 May; 47(6):1180-1187. PubMed ID: 35217796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation.
    Preller KH; Herdener M; Pokorny T; Planzer A; Kraehenmann R; Stämpfli P; Liechti ME; Seifritz E; Vollenweider FX
    Curr Biol; 2017 Feb; 27(3):451-457. PubMed ID: 28132813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD-induced increases in social adaptation to opinions similar to one's own are associated with stimulation of serotonin receptors.
    Duerler P; Schilbach L; Stämpfli P; Vollenweider FX; Preller KH
    Sci Rep; 2020 Jul; 10(1):12181. PubMed ID: 32699231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.
    Pouyan N; Younesi Sisi F; Kargar A; Scheidegger M; McIntyre RS; Morrow JD
    CNS Drugs; 2023 Dec; 37(12):1027-1063. PubMed ID: 37999867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.